Search Results - "Gandhi, Rajesh B"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Subcutaneous Delivery of High-Dose/Volume Biologics: Current Status and Prospect for Future Advancements by Badkar, Advait V, Gandhi, Rajesh B, Davis, Shawn P, LaBarre, Michael J

    Published in Drug design, development and therapy (01-01-2021)
    “…Subcutaneous (SC) delivery of biologics has traditionally been limited to fluid volumes of 1-2 mL, with recent increases to volumes of about 3 mL. This…”
    Get full text
    Journal Article
  2. 2

    Grouping solvents by statistical analysis of solvent property parameters: implication to polymorph screening by Gu, Chong-Hui, Li, Hua, Gandhi, Rajesh B, Raghavan, Krishnaswamy

    Published in International journal of pharmaceutics (28-09-2004)
    “…The success rate of discovering new polymorphs by crystallization from solution may be increased if solvents with diverse properties are used during initial…”
    Get full text
    Journal Article
  3. 3

    Predicting effect of food on extent of drug absorption based on physicochemical properties by GU, Chong-Hui, HUA LI, LEVONS, Jaquan, LENTZ, Kimberley, GANDHI, Rajesh B, RAGHAVAN, Krishnaswamy, SMITH, Ronald L

    Published in Pharmaceutical research (01-06-2007)
    “…To develop a statistical model for predicting effect of food on the extent of absorption (area under the curve of time-plasma concentration profile, AUC) of…”
    Get full text
    Journal Article
  4. 4

    Investigation of monoclonal antibody fragmentation artifacts in non-reducing SDS-PAGE by Zhu, Zhiqing C., Chen, Yingchen, Ackerman, Michael S., Wang, Bei, Wu, Wei, Li, Bo, Obenauer-Kutner, Linda, Zhao, Rulin, Tao, Li, Ihnat, Peter M., Liu, Jinping, Gandhi, Rajesh B., Qiu, Bo

    “…•First study that systematically compared IAM/NEM in SDS-PAGE artifact inhibition.•The artifact inhibition activity of both agents is concentration…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Enhancement of oral bioavailability of an HIV-attachment inhibitor by nanosizing and amorphous formulation approaches by Fakes, Michael G., Vakkalagadda, Blisse J., Qian, Feng, Desikan, Sridhar, Gandhi, Rajesh B., Lai, Chiajen, Hsieh, Alice, Franchini, Miriam K., Toale, Helen, Brown, Jonathan

    Published in International journal of pharmaceutics (31-03-2009)
    “…BMS-488043 is an HIV-attachment inhibitor that exhibited suboptimal oral bioavailability upon using conventional dosage forms prepared utilizing micronized…”
    Get full text
    Journal Article
  7. 7

    Importance of using physiologically relevant volume of dissolution medium to correlate the oral exposure of formulations of BMS-480188 mesylate by Gu, Chong-Hui, Gandhi, Rajesh B., Tay, Lee K., Zhou, Simon, Raghavan, Krishnaswamy

    Published in International journal of pharmaceutics (09-01-2004)
    “…BMS-480188 is a weak base. The aqueous solubility of BMS-480188 is 0.036 mg/ml at pH 6.5 at 37 °C. The mesylate salt of BMS-480188 was prepared to improve its…”
    Get full text
    Journal Article
  8. 8

    Using a novel multicompartment dissolution system to predict the effect of gastric pH on the oral absorption of weak bases with poor intrinsic solubility by Gu, Chong-Hui, Rao, Deepa, Gandhi, Rajesh B, Hilden, Jon, Raghavan, Krishnaswamy

    Published in Journal of pharmaceutical sciences (01-01-2005)
    “…A novel multicompartment dissolution system was developed by modifying a conventional six-vessel United States Pharmacopoeia dissolution system to study the…”
    Get more information
    Journal Article
  9. 9
  10. 10
  11. 11

    Investigation of freeze/thaw-related quality attributes of a liquid biopharmaceutical formulation: the role of saccharide excipients by Zhou, Rong, Schlam, Roxana F, Yin, Shawn, Gandhi, Rajesh B, Adams, Monica L

    “…Saccharides, including sucrose, trehalose, mannitol, and sorbitol, are commonly employed as stabilizers, cryoprotectants, and/or tonicity adjusters in protein…”
    Get more information
    Journal Article
  12. 12

    Subcutaneous Delivery of High-Dose/Volume Biologies: Current Status and Prospect for Future Advancements by Badkar, Advait V, Gandhi, Rajesh B, Davis, Shawn P, LaBarre, Michael J

    Published in Drug design, development and therapy (31-01-2021)
    “…Subcutaneous (SC) delivery of biologies has traditionally been limited to fluid volumes of 1-2 mL, with recent increases to volumes of about 3 mL. This…”
    Get full text
    Journal Article
  13. 13

    Some permselectivity and permeability characteristics of rabbit buccal mucosa by Gandhi, Rajesh B

    Published 01-01-1990
    “…Some permselectivity and permeability characteristics of the rabbit buccal mucosa, as related to buccal absorption of drugs, were investigated. Transport…”
    Get full text
    Dissertation